Retatrutide, by Soma, represents a exciting advance in metabolic control . This innovative medication combines GLP-1 signaling activity with another receptor agonist stimulation , indicating remarkable potential in clinical studies for weight loss . Scientists believe the drug could provide a new solution for patients facing excess weight condition